Faezeh Aghajani

Dr. Faezeh Aghajani

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Iranian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
ANAmin Nakhostin-Ansari
Amin Nakhostin-Ansari
ASAlborz Sherafati
Alborz Sherafati
FAFaezeh Aghajani
Faezeh Aghajani
MKMohammadSaeid Khonji
MohammadSaeid Khonji
RAReyhaneh Aghajani
Reyhaneh Aghajani
NSNazila Shahmansouri
Nazila Shahmansouri
Objective: COVID-19 has spread throughout the world and has become a global pandemic. This situation can cause psychological distress among people, especially health care workers. This study aimed to determine depression and anxiety levels among Iranian medical students during the COVID-19 pandemic. Method: In this cross sectional study, we designed an online survey of Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) questionnaires. The survey link was sent to 500 medical clerks and interns studying at Tehran University of Medical Sciences (TUMS). Results: A total of 64.6% of the students completed the survey. The prevalence of mild to severe anxiety and depression among them was 38.1% and 27.6%, respectively. Anxiety and changes in sleep patterns were the most common symptoms. Higher levels of anxiety were related to female gender, lower grade point average (GPA), and experience of COVID-19 symptoms. Students with lower GPA and prior experience of COVID-19 symptoms were more likely to feel depressed. Conclusion: Depression and anxiety did not significantly differ among Iranian medical students before and after the COVID-19 outbreak. Somatic symptoms of depression are more common during this pandemic and need particular attention in future similar situations. A higher GPA is related to lower anxiety and depression among medical students.

1 September 2023 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
Amir ValizadehAmir Valizadeh
Amir Valizadeh
MMMana Moassefi
Mana Moassefi
ANAmin Nakhostin-Ansari
Amin Nakhostin-Ansari
SSSoheil Heidari Some’eH
Soheil Heidari Some’eH
HHHossein Hosseini-Asl
Hossein Hosseini-Asl
AMAmir Hossein Memari
Amir Hossein Memari
Autism spectrum disorder (ASD) represents a panel of conditions that begin during the developmental period and result in impairments of personal, social, academic, or occupational functioning. Early diagnosis is directly related to a better prognosis. Unfortunately, the diagnosis of ASD requires a long and exhausting subjective process. We aimed to review the state of the art for automated autism diagnosis and recognition in this research. In February 2022, we searched multiple databases and sources of gray literature for eligible studies. We used an adapted version of the QUADAS-2 tool to assess the risk of bias in the studies. A brief report of the methods and results of each study is presented. Data were synthesized for each modality separately using the Split Component Synthesis (SCS) method. We assessed heterogeneity using the I 2 statistics and evaluated publication bias using trim and fill tests combined with ln DOR. Confidence in cumulative evidence was assessed using the GRADE approach for diagnostic studies. We included 344 studies from 186,020 participants (51,129 are estimated to be unique) for nine different modalities in this review, from which 232 reported sufficient data for meta-analysis. The area under the curve was in the range of 0.71–0.90 for all the modalities. The studies on EEG data provided the best accuracy, with the area under the curve ranging between 0.85 and 0.93. We found that the literature is rife with bias and methodological/reporting flaws. Recommendations are provided for future research to provide better studies and fill in the current knowledge gaps.

19 August 2023 in Prenatal Diagnosis
Verified
Journal Article
Closed access
HMHiba J. Mustafa
Hiba J. Mustafa
FAFaezeh Aghajani
Faezeh Aghajani
MJMohammad Jawwad
Mohammad Jawwad
NSNensi Shah
Nensi Shah
AAAlfred Abuhamad
Alfred Abuhamad
Asma KhalilAsma Khalil
Asma Khalil

17 August 2017 in Gynecological Surgery
Verified
Journal Article
Open access
PDF file
ATAfsaneh Tehranian
Afsaneh Tehranian
RZRoghayeh Hassani Zangbar
Roghayeh Hassani Zangbar
FAFaezeh Aghajani
Faezeh Aghajani
MSMahdi Sepidarkish
Mahdi Sepidarkish
SRSaeedeh Rafiei
Saeedeh Rafiei
TETayebe Esfidani
Tayebe Esfidani
Background: The aim of this study was to investigate the effect of salpingectomy on ovarian function by measuring AMH. Methods: This study was a balanced, single-center, double-blind, randomized, controlled trial in Ruin Tan Arash Hospital, Tehran, between May 2013 and November 2014. A total of 30 patients undergoing elective abdominal hysterectomy were randomized into two groups, 15 with salpingectomy and 15 without salpingectomy. The primary objective of this study was to compare mean difference of anti-Mullerian hormone (AMH) between two groups. The secondary outcomes measured were follicle-stimulating hormone (FSH), operative time, and blood loss. Results: Serum AMH levels decreased at 3 months after hysterectomy in all patients (pre AMH 1.32 ± (0.91); post AMH 1.05 ± (0.88), P < 0.001), the salpingectomy group (pre AMH 1.44 ± (0.94); post AMH 1.13 ± (0.86), P < 0.001), and no salpingectomy group (pre AMH 1.2 ± (0.9); post AMH 0.97 ± (0.92), P < 0.001). The rate of decline of AMH levels after surgery did not differ between the two groups (25% (17–33%) vs. 26% (15–36%), P = 0.23) among the women with salpingectomy versus without salpingectomy, respectively. There was no difference in the mean operative time (mean difference 0.33, 95% CI − 22.21 to 22.86, P < 0.92), mean blood loss (mean difference − 0.66, 95% CI − 15.8 to 14.46, P < 0.97), and post FSH (mean difference 0.34, 95% CI − 1.2 to 1.88, P < 0.65) between both groups. Conclusions: Salpingectomy with abdominal hysterectomy is a safe treatment that does not have a deleterious effect on ovarian reserve. Trial registration: Iranian Registry of Clinical Trials, IRCT2014123118866N4 (www.IRCT.ir)

30 October 2023 in Prenatal Diagnosis
Verified
Journal Article
Open access
HMHiba J. Mustafa
Hiba J. Mustafa
FAFaezeh Aghajani
Faezeh Aghajani
ZBZinah A. Bairmani
Zinah A. Bairmani
Asma KhalilAsma Khalil
Asma Khalil
Ebstein anomaly (EA) is a rare congenital cardiac malformation associated with high perinatal mortality. In this systematic review and meta‐analysis, we aimed to investigate the outcomes of pregnancies affected by EA or tricuspid valve dysplasia (TVD) with circular shunt, focusing on two prenatal management approaches: (1) expectant management (EM) and (2) transplacental non‐steroidal anti‐inflammatory drugs (NSAID) therapy. We searched PubMed, Scopus, and Web of Science systematically from its inception until June 2023. The random‐effect model was used to pool the data. Heterogeneity was assessed using the I2 value. Twenty‐one studies with a total of 610 fetuses with EA/TVD with circular shunt were included in the synthesis, of which 17 studies (583 fetuses) were on EM and 4 studies (27 fetuses) used transplacental NSAID therapy. The NSAID group had higher rates of moderate to severe tricuspid regurgitation, hydrops, and pericardial effusion on prenatal ultrasound compared with the EM group. However, ductal constriction was achieved in 81% of NSAID cases, mitigating the disease pathophysiology, although 65% of them experienced oligohydramnios. Notably, the NSAID group showed significantly higher rates of live birth (86%) and survival to hospital discharge (89%) compared with the EM group (67% and 43%, respectively). Despite these promising results, it's important to acknowledge that the number of cases treated with NSAIDs was small, with limited safety data. Therefore, caution is advised in interpreting these findings, and patients considering NSAID therapy should be informed about these limitations. Future multicenter studies are necessary to further explore the safety and effectiveness of NSAID therapy in this particular population.

5 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CSClaudio Vittorio Schenone
Claudio Vittorio Schenone
FAFaezeh Aghajani
Faezeh Aghajani
AJAli Javinani
Ali Javinani
EKEyal Krispin
Eyal Krispin
YOYinka Oyelese
Yinka Oyelese
ASAlireza A. Shamshirsaz
Alireza A. Shamshirsaz
In pregnancies with vasa previa, prenatal diagnosis and pre-labor cesarean delivery are associated with significantly improved perinatal outcomes compared to undetected cases. However, a universally accepted ultrasonographic definition of vasa previa is lacking. Specifically, the distance from the cervical internal os beyond which vaginal delivery can be safely recommended remains to be determined. Field experts and recently published societal guidelines agree that a 2 cm cut-off is suboptimal, given that complete cervical dilation during labor risks unprotected fetal vessels within a 5 cm radius from the internal os. Thus, in the setting of a scarcity of evidence and case reports of perinatal death with unprotected fetal vessels beyond 2 cm from the internal os, a more conservative definition that includes unprotected fetal vessels located within 5 cm of the internal os is imperative to improve outcomes.